about
Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe.Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study).Consensus Decision Models for Biologics in Rheumatoid and Psoriatic Arthritis: Recommendations of a Multidisciplinary Working Party.Influence of Continuing Medical Education on Rheumatologists' Performance on National Quality Measures for Rheumatoid Arthritis.Secukinumab: A New Treatment Option for Psoriatic ArthritisAn Update on Treatment and Management of Pediatric Systemic Lupus ErythematosusCollagenase Treatment in Dupuytren Contractures: A Review of the Current State Versus Future NeedsReview of Osteosarcoma and Current ManagementEmerging Therapies for Rheumatoid ArthritisJuvenile Idiopathic Arthritis: Diagnosis and TreatmentRituximab for Rheumatoid Arthritis.Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous TocilizumabFirst Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study.Delays in Initiation of Disease-Modifying Therapy in Rheumatoid Arthritis Patients: Data from a US-Based Registry.Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data SourcesConcomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis.Osteosarcoma Overview.Estimating the Cost of Illness of Giant Cell Arteritis in the United States.Improvements in Fatigue in 1536 Patients with Rheumatoid Arthritis and Correlation with Other Treatment Outcomes: A Post Hoc Analysis of Three Randomized Controlled Trials of Abatacept.Generating Individual Patient Preferences for the Treatment of Osteoarthritis Using Adaptive Choice-Based Conjoint (ACBC) AnalysisEvaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid ArthritisDepression Risk in Patients with Rheumatoid Arthritis in the United Kingdom.Adalimumab with Methotrexate in Treatment-Naïve Japanese Patients with Rheumatoid Arthritis at Risk of Progressive Structural Joint Damage: A Postmarketing Observational StudyLong-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients.Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION StudyHypersensitivity to Orthopedic Implants: A Review of the Literature.The Patient Global Assessment of Disease Activity in Rheumatoid Arthritis: Identification of Underlying Latent Factors.Comparison of Biologic Disease-Modifying Antirheumatic Drug Therapy Persistence Between Biologics Among Rheumatoid Arthritis Patients Switching from Another Biologic.Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis.Assessing Methotrexate Adherence in Rheumatoid Arthritis: A Cross-Sectional SurveyThe Tissue-Selective Estrogen Complex: A Review of Current EvidenceEpigenetic Aspects of Systemic Lupus Erythematosus.Characteristics Associated with Biologic Monotherapy Use in Biologic-Naive Patients with Rheumatoid Arthritis in a US Registry Population.Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis.Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis.Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis.Pharmacokinetics and Bioequivalence Study of Hydroxychloroquine Sulfate Tablets in Chinese Healthy Volunteers by LC-MS/MS.Use of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs.Predictors of Atherosclerosis in Ankylosing Spondylitis.Biologics Prescribing for Rheumatoid Arthritis in Older Patients: A Single-Center Retrospective Cross-Sectional Study.
P1433
Q27335007-3A297B67-0E3F-4069-A402-00AFD3B5AECAQ27335031-4AC786AA-FA59-4608-A5F5-0861A153ADD6Q27335069-35D737B7-2AD8-47AE-B63F-4E109350A700Q27335103-3FBCB6E2-A6D2-463E-8D49-04FBE600BC2DQ28066204-2191E993-2711-442E-902C-22AAF2759F17Q28074348-7C86503F-EBCD-4731-8FBC-A76DFAEEE22FQ28077588-361314E4-A31E-4ED0-BA8F-47ABC1CFD727Q28077590-8313719B-7E8C-49BE-B4EA-196EFAF4DA75Q28078943-45D932B3-0ECE-4562-AE42-98D6EA62BB4CQ28079246-F2D8A0A0-6225-43A5-B7AE-4B7F83DAEA90Q28080246-3ACE5FE7-4AA5-48D7-AD64-9FAEE5B4E26BQ28080677-370EAEE9-D201-4D33-A6C3-BBA5317F8DF9Q30490276-EDDAA846-E0D3-418B-8A3A-888FFA416245Q31137075-04C647D6-79CC-492D-AEF5-D41242A2EE44Q31137082-7ED6D80B-7847-4305-978E-28B2E78FD187Q33725505-7B23896E-5211-48F0-8ACF-B7723D489150Q33725511-0357C548-221C-4C55-B162-02EF215DD04FQ33725515-B3B0D3E4-9029-4135-9E03-8B5F582E503BQ33725521-CA29B777-5F83-42FD-B928-B70B33E1B945Q33725528-F4B47BCA-E886-4407-8F47-0F95FF196396Q33725535-5B1FDC43-4F67-4321-8A60-BD8A93782D99Q33725540-D8BB24A5-CD40-41C1-BAE8-91E67A2C9D17Q33725547-3D326216-4D11-420B-A343-24E57B8F4A2EQ33725553-C2A79023-ABC8-4116-9454-69616122FFDAQ33725559-FF6923DF-A5DA-4608-8757-D0D2957FA93EQ33725566-EE84E7B5-716B-4422-BFCD-28D2F8BD287CQ33725571-D8C32ECF-5CB3-421F-A56C-CF18BB892B4BQ36942952-F1686FA4-1336-4BB9-9410-36CC83A51566Q36942960-96A15D61-914E-4E81-B351-5C2C2D9CBFE8Q36942965-11E9FBA9-BD58-497F-A0E5-8D0A2951613DQ36942968-817926C6-310F-404C-A0D8-463D556E0FFCQ36942972-91D826EE-53BD-49CA-BA8C-82FCE9C3D1A4Q36942975-CA45F8E4-A27B-4E0E-B814-FC0EB43652D0Q36942978-A29639E4-C7E0-460D-BF5C-BA301357DFB3Q36942985-32E83574-4CA4-4283-B479-CBDDD962F24BQ36942993-18142F78-A500-42B5-9D00-911E7E870FA3Q36942997-34D197B6-1891-4949-A82E-5688A1FEDA33Q36943002-3973ED8B-73A2-4193-896B-D42E81E615BAQ36943007-0B847515-E681-415D-9A49-EFC2E93C4D42Q36943015-08104ABD-895B-4AEF-A587-BBADD418FD31
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift van Adis, Springer Healthcare
@nl
wissenschaftliche Fachzeitschrift
@de
name
Rheumatology and therapy
@ast
Rheumatology and therapy
@en
Rheumatology and therapy
@es
Rheumatology and therapy
@nl
type
label
Rheumatology and therapy
@ast
Rheumatology and therapy
@en
Rheumatology and therapy
@es
Rheumatology and therapy
@nl
altLabel
Rheumatol Ther
@en
Rheumatology and Therapy
@en
prefLabel
Rheumatology and therapy
@ast
Rheumatology and therapy
@en
Rheumatology and therapy
@es
Rheumatology and therapy
@nl
P31
P3181
P1055
P1476
Rheumatology and therapy
@en